drugset / Trial / NCT02512471

The Minimum Effective Volume of Ropivacaine in Ultrasound-guided Supraclavicular Block

NCT02512471 ↗

Non-randomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study is to determine the minimum effective volume of local anesthetic (ropivacaine 0.275% and 0.325%) required to produce an effective double-injection USG-SCB for surgical anesthesia in 90% of patients (MEV90) in young group (18-40 years) and in middle aged group (40-65 years) of patients scheduled for elective surgery of one upper limb distal to the shoulder.

Timeline

Start
2015-05
Primary completion
2015-09
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 0.275 % —
Subject Ropivacaine Other / unclassified 0.325 % —

Indications

No indication recorded.